A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable pancreatic adenocarcinoma

被引：0
|
作者：
Koenig, Julie L.
Pappas, Leon
Yeap, Beow Y.
Clark, Jeffrey William
Weekes, Colin D.
Allen, Jill N.
Blaszkowsky, Lawrence Scott
Ryan, David P.
Cleary, James M.
Mancias, Joseph Douglas
Schlechter, Benjamin L.
Slater, Sarah Elizabeth
Wo, Jennifer Yon-Li
Roberts, Hannah Johnson
Von Fedak, Sofia
Carzo, Nicole
Drapek, Lorraine C.
Mehta, Arnav
Hong, Theodore S.
Parikh, Aparna Raj
机构：
[1] Harvard Radiat Oncol Program, Boston, MA USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Div Hematol & Oncol, Dept Med, Boston, MA USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[4] Dana Farber Canc Inst, Boston, MA USA
[5] Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA USA
[6] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4143
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma
    Sapna P. Patel
    Dae Won Kim
    Roland L. Bassett
    Suzanne Cain
    Edwina Washington
    Wen-Jen Hwu
    Kevin B. Kim
    Nicholas E. Papadopoulos
    Jade Homsi
    Patrick Hwu
    Agop Y. Bedikian
    Cancer Immunology, Immunotherapy, 2017, 66 : 1359 - 1366
  • [42] A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma
    Patel, Sapna P.
    Kim, Dae Won
    Bassett, Roland L.
    Cain, Suzanne
    Washington, Edwina
    Hwu, Wen-Jen
    Kim, Kevin B.
    Papadopoulos, Nicholas E.
    Homsi, Jade
    Hwu, Patrick
    Bedikian, Agop Y.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (10) : 1359 - 1366
  • [43] Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study
    Pelster, Meredith S.
    Gruschkus, Stephen K.
    Bassett, Roland
    Gombos, Dan S.
    Shephard, Michael
    Posada, Liberty
    Glover, Maura S.
    Simien, Rinata
    Diab, Adi
    Hwu, Patrick
    Carter, Brett W.
    Patel, Sapna P.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06) : 599 - +
  • [44] Phase I/II trial of encorafenib, cetuximab, and nivolumab in patients with microsatellite stable, BRAFV600E metastatic colorectal cancer
    Morris, Van K.
    Parseghian, Christine Megerdichian
    Escano, Michelle
    Johnson, Benny
    Raghav, Kanwal Pratap Singh
    Dasari, Arvind
    Huey, Ryan
    Overman, Michael J.
    Willis, Jason
    Lee, Michael Sangmin
    Wolff, Robert A.
    Kee, Bryan K.
    Shen, John Paul Y. C.
    Morelli, Maria Pia
    Tam, Alda
    Foo, Wai Chin
    Xiao, Lianchun
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [45] A Phase II Study of Nivolumab or Ipilimumab with or without Azacitidine for Patients with Myelodysplastic Syndrome (MDS)
    Garcia-Manero, Guillermo
    Sasaki, Koji
    Montalban-Bravo, Guillermo
    Daver, Naval G.
    Jabbour, Elias J.
    Alvarado, Yesid
    DiNardo, Courtney D.
    Ravandi, Farhad
    Borthakur, Gautam
    Bose, Prithviraj
    Pemmaraju, Naveen
    Naqvi, Kiran
    Cortes, Jorge E.
    Kadia, Tapan M.
    Konopleva, Marina Y.
    Colla, Simona
    Yang, Hui
    Rausch, Caitlin R.
    Gasior, Yvonne
    Bueso-Ramos, Carlos E.
    Kanagal-Shamanna, Rashmi
    Patel, Keyur P.
    Kantarjian, Hagop M.
    BLOOD, 2018, 132
  • [46] Phase II trial of vatalinib in patients with advanced or metastatic pancreatic adenocarcinoma who failed gemcitabine therapy
    Dragovich, T.
    Laheru, D. A.
    Crowley, J. J.
    Smith, L. S.
    Seng, J.
    Burris, H. A., III
    Rosen, P. J.
    Von Hoff, D. D.
    Bolejack, V.
    Hidalgo, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study
    Andre, Thierry
    Tougeron, David
    Piessen, Guillaume
    de la Fouchardiere, Christelle
    Louvet, Christophe
    Adenis, Antoine
    Jary, Marine
    Tournigand, Christophe
    Aparicio, Thomas
    Desrame, Jerome
    Lievre, Astrid
    Garcia-Larnicol, Marie-Line
    Pudlarz, Thomas
    Cohen, Romain
    Memmi, Salome
    Vernerey, Dewi
    Henriques, Julie
    Lefevre, Jeremie H.
    Svrcek, Magali
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (02) : 255 - +
  • [48] A phase I/II study combining tosedostat with capecitabine in patients with metastatic pancreatic adenocarcinoma.
    Teague, Andrea S.
    Amin, Manik A.
    Lim, Kian-Huat
    Lockhart, Albert C.
    Masood, Ashiq
    Picus, Joel
    Singh, Preet Paul
    Suresh, Rama
    Tan, Benjamin R.
    Wang-Gillam, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [49] Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma
    Wolpin, Brian M.
    Rubinson, Douglas A.
    Wang, Xiaoxu
    Chan, Jennifer A.
    Cleary, James M.
    Enzinger, Peter C.
    Fuchs, Charles S.
    McCleary, Nadine J.
    Meyerhardt, Jeffrey A.
    Ng, Kimmie
    Schrag, Deborah
    Sikora, Allison L.
    Spicer, Beverly A.
    Killion, Leah
    Mamon, Harvey
    Kimmelman, Alec C.
    ONCOLOGIST, 2014, 19 (06): : 637 - 638
  • [50] A Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal Tumors
    Singh, Arun S.
    Hecht, J. Randolph
    Rosen, Lee
    Wainberg, Zev A.
    Wang, Xiaoyan
    Douek, Michael
    Hagopian, Anahis
    Andes, Rachel
    Sauer, Lauren
    Brackert, Sandra R.
    Chow, Warren
    DeMatteo, Ronald
    Eilber, Fritz Christian
    Glaspy, John A.
    Chmielowski, Bartosz
    CLINICAL CANCER RESEARCH, 2022, 28 (01) : 84 - 94
12345